Novel Biomarkers for Renal Diseases? None for the Moment (but One). (Q38763898)

6 September 2017

Novel Biomarkers for Renal Diseases? None for the Moment (but One). (English)

1 reference

6 September 2017

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950928%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Giuseppe Remuzzi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950928%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Giorgio Gentile

series ordinal

1

1 reference

6 September 2017

12 February 2016

1 reference

Journal of Biomolecular Screening

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950928%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950928%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

655-670

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950928%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26950928%20AND%20SRC:MED&resulttype=core&format=json

Timing of complications in percutaneous renal biopsy

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Con: Biomarkers in glomerular diseases: putting the cart before the wheel?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Performance of the Cockcroft-Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Performance of different prediction equations for estimating renal function in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Combining GFR and albuminuria to classify CKD improves prediction of ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Proteinuria should be used as a surrogate in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Extracellular microRNA: a new source of biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Proteomic biomarkers in kidney disease: issues in development and implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Proteomics: challenges, techniques and possibilities to overcome biological sample complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

World incidence of AKI: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

The impact of dialysis-requiring acute kidney injury on long-term prognosis of patients requiring prolonged mechanical ventilation: nationwide population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Acute kidney injury in elderly persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Acute kidney injury, mortality, length of stay, and costs in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Survival in patients with acute kidney injury requiring dialysis after coronary artery bypass grafting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

A Pilot Study Identifying a Set of microRNAs As Precise Diagnostic Biomarkers of Acute Kidney Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Blood pressure, proteinuria, and phosphate as risk factors for progressive kidney disease: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Chronic kidney disease: global dimension and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Mechanisms of anemia in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Chronic kidney disease and bone fracture: a growing concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Cognitive disorders and dementia in CKD: the neglected kidney-brain axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Diabetic kidney disease with and without albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Identification and management of albuminuria in the primary care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Can the Urinary Peptidome Outperform Creatinine and Albumin to Predict Renal Function Decline?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Biomarkers in chronic kidney disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Cystatin C and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Do mTOR inhibitors still have a future in ADPKD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Clinical practice. Autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Unified criteria for ultrasonographic diagnosis of ADPKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Molecular diagnostics for autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Advances in urinary proteome analysis and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Glomerular endothelial surface layer acts as a barrier against albumin filtration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

The spectrum of podocytopathies: a unifying view of glomerular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Advances in slit diaphragm signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Neurexin-1, a presynaptic adhesion molecule, localizes at the slit diaphragm of the glomerular podocytes in kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Evolving strategies for renoprotection: diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Clinical practice. Nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

21 January 2018

Retinopathy in diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Current epidemiology of diabetic retinopathy and diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Microalbuminuria and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Kidney-heart interactions: epidemiology, pathogenesis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Race/ethnic difference in diabetes and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

The global burden of diabetes and its complications: an emerging pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Albuminuria in heart failure: what do we really know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Microalbuminuria in nondiabetic and nonhypertensive systolic heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Biomarkers of progression in diabetic nephropathy: The past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urinary microRNA profiling in the nephropathy of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Wilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Elevated matrix metalloproteinase-2 and -9 in urine, but not in serum, are markers of type 1 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urinary mRNA markers of epithelial-mesenchymal transition correlate with progression of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urinary cystatin C and tubular proteinuria predict progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Diabetic nephropathy: traditional to proteomic markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urinary proteomics for early diagnosis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Serum concentration of cystatin C and risk of end-stage renal disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

FGF-23 as a predictor of renal outcome in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Idiopathic membranous nephropathy: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Serum galactose-deficient IgA1 level is not associated with proteinuria in children with IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Expression of microRNAs in the urinary sediment of patients with IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Mechanisms of disease: focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Circulating suPAR in two cohorts of primary FSGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Modification of kidney barrier function by the urokinase receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Serum suPAR in patients with FSGS: trash or treasure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urinary prognostic biomarkers in patients with focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Biomarkers for lupus nephritis: the quest continues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Can we use biomarkers and functional assays to implement personalized therapies in transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Neutrophil gelatinase-associated lipocalin, a new biomarker candidate in perfusate of machine-perfused kidneys: a porcine pilot experiment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

The value of machine perfusion biomarker concentration in DCD kidney transplantations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Identification of biomarkers to assess organ quality and predict posttransplantation outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

MicroRNA expression profiles predictive of human renal allograft status

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Effect of sirolimus withdrawal in patients with deteriorating renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

The elephant in the room: failings of current clinical endpoints in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urine as a source for clinical proteome analysis: from discovery to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

CKD273, a new proteomics classifier assessing CKD and its prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Identifying biomarkers as diagnostic tools in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Pro: 'The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism--individual patient variability in disease presentation, course and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

The contribution of chronic kidney disease to the global burden of major noncommunicable diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Circulating Anti-PLA2R Autoantibodies to Monitor Immunological Activity in Membranous Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916

Urinary Connective Tissue Growth Factor Excretion Correlates With Clinical Markers of Renal Disease in a Large Population of Type 1 Diabetic Patients With Diabetic Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057116629916